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Abstract: Large water fluxes continuously take place between the different compartments of the brain as well as between 
the brain parenchyma and the blood or cerebrospinal fluid. 
Disturbances in this well-regulated water homeostasis may have deleterious effects on brain function and may be fatal in 
cases where water accumulates in the brain following pathologies such as ischemia, haemorrhage, or brain trauma. 
The molecular pathways by which water molecules cross the blood brain barrier are not well-understood, although   
the discovery of Aquaporin 4 (AQP4) in the brain improved the understanding of some of these transport processes,  
particularly under pathological conditions.  
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1. AQUAPORINS AND BLOOD BRAIN BARRIER 
  AQP1 and AQP4 are known to be expressed in the cen-
tral nervous system (CNS), and it is possible that these pro-
teins contribute to water transport across the blood brain 
barrier (BBB). 
1.1. Aquaporin 1 
  In the CNS, AQP1 was demonstrated only in the epithe-
lium (but not in the fenestrated capillaries) of the choroid 
plexus and in the ependyma and pia [29]. Nevertheless, ex-
pression of AQP1 was not detected in freshly isolated rat 
cerebral microvessels, as determined by reverse-
transcriptase–polymerase chain reaction (RT–PCR) and 
western blotting [18]. The brain endothelial phenotype dif-
fers from that of many other tissues; in vivo it is maintained 
by the influence of the apposing astrocytic end-feet, but 
some features can be lost in vitro [15, 25, 26]. However, 
aspects of the phenotype may be up-regulated when the cells 
are co-cultured with astrocytes [1]. The apparent lack of 
AQP1 expression in brain endothelial cells may represent an 
important phenotypic difference among these and the endo-
thelia of many other tissues which support expression of 
AQP1, as determined by immunocytochemistry [29].  
  Recently, it has been demonstrated that primary cultured 
rat brain microvessel endothelial cells express only very low 
levels of AQP1, in agreement with the findings that AQP1 is 
not detectable in cerebral microvessels in situ or when 
freshly isolated [18, 29]. However, AQP1 expression has 
been showed to be greatly up-regulated in passaged cultured 
rat brain microvessel endothelial cells, conditions under 
which de-differentiation is known to occur. In addition,   
the Authors demonstrated that AQP1 mRNA levels can be  
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reduced by co-culture with astrocytes, implicating astrocytic 
factors in the control of AQP1 expression [16].  
 In  vivo the brain endothelial phenotype is induced and 
maintained by the influence of astrocytes; some features, 
such as expression of -glutamyl transpeptidase, can be lost 
in passaged cells but are retained or up-regulated in co-
cultures with astroglial cells [1]. The reverse occurs with 
AQP1: AQP1 mRNA is up-regulated with repeated passag-
ing and decreased by co-culture with astrocytes. This sup-
ports the hypothesis that AQP1 expression is suppressed by 
astrocytic factors; on the contrary, when this astrocytic influ-
ence is absent, AQP1 expression increases.  
  In a study of AQP1 expression in human brain, a small 
number of microvessels were positively stained, but there 
was marked up-regulation in endothelium in astrocytomas 
and metastatic carcinomas; BBB function is known to be 
impaired in such brain tumours, leading to formation of 
edema [35]. Down-regulation of the tight-junction proteins 
claudin and occludin has also been demonstrated in mi-
crovessels in glioblastoma multiforme [19]. Thus, loss of 
barrier function and the expression of AQP1 may both be 
regarded as down-regulation of BBB phenotype. It is not 
possible to say whether this is caused by loss of normal as-
trocyte function; in fact, an increase in microvessel perme-
ability could arise from overexpression of vascular endothe-
lial growth factor (VEGF) in such tumours [34]. However, 
although it is well established that astrocytic factors are   
important in maintaining the tightness of BBB, Dolman and 
co-workers [16] showed that they play a role in reduction  
of endothelial AQP1 expression [1]. This may provide   
an explanation for up-regulation of endothelial AQP1 in   
tumours involving astroglial cells. 
1.2. Aquaporin 4 
  Given its polarized expression bordering the BBB and 
the brain–cerebrospinal fluid interface, AQP4 has been pre-
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water in and out of the brain parenchyma by enhancing 
transmembrane water flux in astrocytes [38] Fig. (1). Sole-
nov and colleagues [39] demonstrated that astrocytes lacking 
AQP4 had sevenfold reduced water permeability, as com-
pared with equivalent cells with normal AQP4 expression. 
The functional importance of AQP4-facilitated water trans-
port in diseases of cerebral water imbalance has been primar-
ily tested in vivo using mice with altered or absent AQP4 
expression [12].  
 
 
 
 
 
 
 
 
 
 
Fig. (1). Double immunolabeling of AQP4 (red) and glial fibrillary 
acidic protein (GFAP) (green) in cortex. AQP4 immunolabeling 
reveals that the entire network of vessels, including capillaries, is 
covered by astrocytic processes, albeit GFAP negative. Smaller 
vessels and capillaries are mostly GFAP negative but display in-
tense labeling against the astrocyte-specific channel AQP4. The 
AQP4 labeling reveals continuous coverage by astrocytic end feet. 
Figures from Simard et al. [38], reprinted with permission of Soci-
ety of Neuroscience. 
  The lack of an apparent phenotype of the AQP4 knock-
out mice also suggested that the role of AQP4 under normo-
physiological conditions might be limited [20]. However, 
during pathological conditions leading to the formation of 
brain edema, AQP4 is an important player. Knock-out of 
AQP4 or disruption of its polarized expression pattern miti-
gated the brain water accumulation associated with brain 
ischemia, water intoxication, and hyponatremia [3, 4, 6, 22, 
47], suggesting that during pathophysiological conditions, 
AQP4 is a main entrance route for water from the plasma 
and into the brain.  
  The role of AQP4 in CNS water balance is now well 
characterized. AQP4 deficiency reduced cytotoxic edema 
produced by water intoxication, cerebral hischemia and acute 
bacterial meningitis [22, 32], but increases vasogenic edema 
caused by brain tumour, cortical freeze injury, brain abscess 
and kaolin-induced obstructive hydrocephalus [11, 13, 31]. 
2. AQUAPORINS AND BRAIN EDEMA 
  Cerebral edema is due to abnormally increased water 
content and consequent brain swelling in different patho-
physiological pathway of CNS vascular diseases. 
  The recent identification of AQPs has consented to un-
derstand the basis of the water transport in many tissues, 
including CNS. Since brain edema continues to be the main 
cause of death from several CNS diseases, including brain 
infarct, haemorrhage, tumour, trauma and infection, the in-
terest in AQPs and their functional contribution to the water 
balance is due to their possible therapeutic role in managing 
brain edema [2, 5, 10, 22]. Data on AQP expression in cere-
bral edema, particularly AQP1 and AQP4, which are ex-
pressed in the CNS and participate in water transport across 
the BBB, come from some recent studies of large ischemic 
strokes [9, 16, 43]. 
  The presence of AQP4 at the BBB suggests that it is im-
portant for the brain water balance and may play a critical 
role in brain edema [28]. AQP4 over-expression in human 
astrocytomas correlates with detection of brain edema on 
magnetic resonance imaging [35, 45]. However, under-
expression of AQP4 protein is associated with early stage 
edema in rodents subjected to permanent focal brain ische-
mia and hypoxia-ischemia [14, 24]. In traumatic brain injury 
AQP4 mRNA is decreased in the edematous area adjacent to 
a cortical contusion [41]. 
2.1. Vasogenic Edema 
  Data from studies of AQP4 knock-out mice suggest that 
AQP4 is involved in clearing extracellular fluid from the 
brain parenchyma in vasogenic edema Fig. (2). In several 
models where vasogenic edema is the predominant form of 
edema, there is a significantly greater increase in brain water 
content and intracranial pressure. This has been documented 
in AQP4 knock-out mice compared with their wild-type 
counterparts, suggesting impaired brain water elimination 
following AQP4 deletion [31, 33]. In addition, observations 
in AQP4 knock-out mice with water intoxication and focal 
cerebral ischemia suggested that in vasogenic edema water 
enters the brain parenchyma independently of AQP4, but 
exits the brain through AQP4. This finding is intriguing, 
because excess fluid seems to enter the extracellular space of 
the brain parenchyma, but to exit using a transcellular path-
way [21]. Other data hypothesized that hypertonic saline 
exerts its anti-edema effect by promoting an efflux of water 
from brain via the perivascular AQP4 pool.  
2.2. Cytotoxic Edema 
  Swelling of astrocytic foot processes is a major finding in 
cytotoxic edema Fig. (2); since this is where AQP4 channels 
are located, the hypothesis has been advanced that they may 
have a role in cell swelling. AQP4 knock-out mice with 
ischemic stroke [22] and bacterial meningitis [32] showed 
decreased cerebral edema and improved outcomes. Reduced 
brain swelling after cerebral ischemia and water intoxication 
is also observed in -syntrophin knock-out mice, which ex-
hibit reduced AQP4 expression in astrocytic foot processes 
[4]. 
  Lactic acidosis, which takes place in the brain during 
cerebral ischemia [37], seems to play a role in the develop-
ment of cytotoxic edema [40], since lactic acid leads to swel-
ling in cultured rat astrocytes; moreover, an increase of 
AQP4 expression has been demonstrated on the astrocyte 
cell membrane as well as AQP9 permeability [27]. In the 
latter case, lactate and glycerol could be cleared from the 
extracellular space during ischemia, with the participation of 
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lactate has been shown to help neuronal recovery after 
ischemic insults [36]. 
2.3. Hydrocephalic Edema 
  Hydrocephalus is the result of an imbalance between 
cerebrospinal fluid (CSF) production and resorption, leading 
to an expansion of the ventricular system and to increased 
intracerebral pressure [42]. The latter event drives flow from 
the ventricles into the parenchyma, leading to extracellular 
edema, especially in subventricular white matter [46]. A re-
cent study has documented that AQP4 is upregulated in 
periventricular white matter of hydrocephalic rats, and that 
up-regulation increases with disease severity, supporting an 
adaptive response aimed at clearing excess fluid [42]. 
  Obstructive hydrocephalus, produced by kaolin injection 
into the cistern magna, induced faster ventricular enlarge-
ment in AQP4 knock-out than in wild-type mice. The dimin-
ished water permeability of ependymal layer, subependymal 
astrocytes, astrocytic foot processes and glia limitans pro-
duced by AQP4 deletion lessens the elimination rate of CSF 
through these routes [12]. 
  Moreover AQP1 knock-out mice show a 25% reduction 
in the rate of CSF secretion, reduced osmotic permeability of 
choroid plexus epithelium, and decreased intracranial pres-
sure [30]. These findings support a role for AQP1 in facilit-
ing CSF secretion into the cerebral ventricles by the choroid 
plexus, and support the hypothesis of a role for AQP1 inhibi-
tors in treating hydrocephalus and benign intracranial hyper-
tension, both of which are associated with CFS formation or 
accumulation [28]. 
3. THERAPEUTICAL IMPLICATIONS 
  Data from immunostaining and protein quantification in 
human and animal tissues demonstrate up-regulation of 
AQP4 expression in primary brain tumours and stroke, and 
after traumatic brain injury [7, 35, 44]. Although the signal-
ing pathways involved in disease-related expression up-
regulation remain unknown, up-regulation in response to 
hormonal and osmotic stimulants has been demonstrated in 
cultured astrocytes [8, 17]. It is only a matter of time before 
small molecular compounds that can inhibit AQP4 function 
and up-regulate AQP4 expression become available, as sev-
eral investigative groups have already begun testing for such 
compounds [12]. 
  Drugs that target AQP4 function would provide a major 
therapeutic advancement in the treatment of all forms of 
cerebral edema, working synergistically with current thera-
pies. 
  The current approach in nonsurgical treatment of edema 
consists primarily of systemic hypertonic fluid and corticos-
teroid administration, considered standard therapies of care 
for decades [23]. Steroids are primarily beneficial in ex-
tracellular (vasogenic) edema by suppressing inflammatory 
mediator release, thereby limiting BBB permeability and 
preventing the extracellular accumulation of edema fluid. 
This approach to edema is primarily preventative, and is 
more effective in early edema development. 
  In contrast, hypertonic fluids such as mannitol are effec-
tive in intracellular and extracellular edema, drawing edema 
fluid from the parenchyma into the vasculature, thereby en-
hancing the clearance of edema. Although temporarily effec-
tive in the treatment of malignant intracerebral pressure, hy-
pertonic therapy does not prevent edema formation, and par-
enchymal fluid will re-accumulate after hypertonic treatment 
if the underlying condition is not addressed. By selectively 
enhancing or suppressing AQP4 activity in particular disease 
states, both the formation and clearance of edema from any 
cause can be targeted, providing effective therapy at any 
stage in the progression of disease. 
  Blocking AQP4 function, as seen in the studies of water 
intoxication and stroke, decreases the rate of edema forma-
tion and enhances survival. Coupled with hypertonic therapy, 
AQP4 inhibitors would be expected to limit the re-
accumulation of edema after treatment with hypertonic flu-
ids, making combined treatment longer lasting and more 
effective. Similarly, the use of AQP4 expression up-
regulators would enhance edema fluid resorption in extracel-
lular edema and could be combined with corticosteroid ad-
ministration to more rapidly resolve edema associated with 
tumours and infection/inflammation [12].  
  The development of AQP4 modulating agents should be 
the future of molecularly targeted cerebral edema therapy. 
 
 
 
 
 
 
Fig. (2). Proposed mechanism of AQP4 involvement in edema fluid formation. (A) In cytotoxic edema, the entry of excess fluid into the 
brain parenchyma is AQP4 dependent, because edema fluid flows from the vascular compartment, through intact BBB and AQP4-rich  
astrocyte foot processes, and accumulates primarily in astrocytes. (B) In vasogenic edema, water accumulation is AQP4-independent because 
the BBB is leaky, permitting the entry of plasma fluid directly into the brain ECS circumventing astrocyte foot processes. Aquaporin and Blood Brain Barrier  Current Neuropharmacology, 2010, Vol. 8, No. 2    95 
CONCLUSIONS 
  During the past two decades, the understanding of   
brain water physiology has progressed from the discovery of 
AQPs to the characterisation of their physiological and 
pathological functions.  
  The polarized distribution of AQP4 in the perivascular 
astrocyte end-feet suggests that AQPs may be important in 
the function of the barrier as a whole, that is, endothelium 
plus astrocytes, although the endothelial cells themselves 
express at most only very low levels of AQP. This body of 
work suggests that AQP modulation may have several clini-
cal uses. Although AQP modulating drugs are not currently 
available, studies are under way using high-throughput 
screening of chemical libraries to discover AQP4 modulators 
that could be used for treating several brain conditions in-
cluding trauma, tumour, hydrocephalus and seizures. 
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